Makena Approved to Treat Preterm Labor

Makena Approved to Treat Preterm Labor

Premature infant nicu

The FDA has approved Makena™ (hydroxyprogesterone caproate injection), formerly known as 17P, to reduce the risk of preterm birth.  Makena™ is the only treatment that is FDA approved.  Women who are eligible for Makena™ are moms who are carrying only one baby and have a history of a preterm birth.  While this is only a certain portion of moms who experience preterm labor, it is still helpful.

Read Full Post

Potrebbero interessarti anche...